144 related articles for article (PubMed ID: 7357079)
1. Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor.
Aoki N; Sakata Y; Matsuda M; Tateno K
Blood; 1980 Mar; 55(3):483-8. PubMed ID: 7357079
[No Abstract] [Full Text] [Related]
2. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
Ries M; Zenker M; Gaffney PJ
Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
[TBL] [Abstract][Full Text] [Related]
3. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Suenson E; Thorsen S
Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
[TBL] [Abstract][Full Text] [Related]
4. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
5. The fibrinolytic system in man.
Collen D; Lijnen HR
Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
[TBL] [Abstract][Full Text] [Related]
6. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
Trübestein G; Popov S; Wolf H; Welzel D
Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
[TBL] [Abstract][Full Text] [Related]
7. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
Sugiyama N; Iwamoto M; Abiko Y
Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
[TBL] [Abstract][Full Text] [Related]
8. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
9. Inherited disorders of the fibrinolytic pathway.
Jain S; Acharya SS
Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
11. Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.
Aoki N; Sakata Y; Ichinose A
Blood; 1983 Nov; 62(5):1118-22. PubMed ID: 6626743
[TBL] [Abstract][Full Text] [Related]
12. Effects of tranexamic acid on fibrinolysis, fibrinogenolysis and amidolysis.
Takada A; Makino Y; Takada Y
Thromb Res; 1986 Apr; 42(1):39-47. PubMed ID: 3705023
[TBL] [Abstract][Full Text] [Related]
13. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
14. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
Lee KN; Jackson KW; McKee PA
Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic properties of plasmins converted from acid-treated and native Glu- and Lys-plasminogens by urokinase.
Takada A; Takada Y
Thromb Res; 1981 Mar; 21(6):593-601. PubMed ID: 6455775
[No Abstract] [Full Text] [Related]
16. Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.
Takada Y; Takada A
Thromb Res; 1979; 16(5-6):865-9. PubMed ID: 160629
[No Abstract] [Full Text] [Related]
17. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
18. Role of alpha 2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage.
Hayashi S; Yamada K
Thromb Res; 1979; 16(3-4):393-400. PubMed ID: 92817
[No Abstract] [Full Text] [Related]
19. Acceleration of plasma clot lysis by an antibody to alpha 2-antiplasmin.
Reed GL; Matsueda GR; Haber E
Trans Assoc Am Physicians; 1988; 101():250-6. PubMed ID: 2480017
[No Abstract] [Full Text] [Related]
20. Interaction of plasmin with alpha 2-macroglobulin and alpha 2-antiplasmin in the presence and absence of tranexamic acid.
Takada A; Takada Y
Thromb Res; 1980 Apr 1-15; 18(1-2):237-46. PubMed ID: 6157220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
